Coral Laboratories Ltd.
BSE: 524506 | Sector: Health care |
NSE: N.A. | ISIN Code: INE683E01017 |
BSE 00:00 | 04 Jul | 242.00 |
0 (0.00%) |
OPEN
241.90 |
HIGH
242.00 |
LOW
235.65 |
NSE 05:30 | 01 Jan | Coral Laboratories Ltd |
OPEN | 241.90 |
PREVIOUS CLOSE | 242.00 |
VOLUME | 2018 |
52-Week high | 471.00 |
52-Week low | 225.05 |
P/E | 10.39 |
Mkt Cap.(Rs cr) | 86 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Coral Laboratories Ltd. (CORALLABS) - Company Information
Coral Laboratories Limited has been promoted by Navin B Doshi of the DWD group. The Company is spearheaded by Kishor R Mehta as Executive Director. CLL produces various pharmaceutical formulations. To Manufacture pharmaceutical formulations like tabletscapsules the company went into public issue in March 94 at a total cost of Rs.2.5 crores. The project has been completed successfully CLL plans to ...> More
COMPANY INFORMATION | |||||||
Independent Director : | Sheela R Kamdar | ||||||
Whole-time Director : | Girish Dhameja | ||||||
Director & CFO : | Sushma Shashi Kadkade | ||||||
Independent Director : | Saurabh Shah | ||||||
Company Secretary : | Ruchi Anjaria | ||||||
Addtnl Independent Director : | Malay Doshi | ||||||
Additional Director : | Rajendrasinh Rana | ||||||
AUDITOR : | M A Parekh & Associates | ||||||
IND NAME : | Pharmaceuticals - Indian - Formulations | ||||||
HOUSE NAME : | Coral | ||||||
Registered office | |||||||
SF-206 Silver Oak Complex, BPC Road,Vadodara,Gujarat-390020 | |||||||
Ph : 91-022-2500 5245/46 | |||||||
WEBSITE : http://www.corallab.com | |||||||
E-mail : cs@corallab.com |
Quick Links for Coral Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices